Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancer
Hongxiang Zhang(Tango Therapeutics (United States)), Teng Teng(Tango Therapeutics (United States)), Madhavi Bandi(Tango Therapeutics (United States)), Lauren Martires(Tango Therapeutics (United States)), Chengyin Min(Acetylon Pharmaceuticals (United States)), Tenzing Khendu(Tango Therapeutics (United States)), Jannik N. Andersen(Tango Therapeutics (United States)), Alan Huang(Tango Therapeutics (United States)), Yi Yu(Novartis (United States)), Xuewen Pan(Baylor College of Medicine), Shangtao Liu(Tango Therapeutics (United States)), Ashley H. Choi(Tango Therapeutics (United States)), Shan-Chuan Zhao(Takeda (Japan)), Binzhang Shen(Tango Therapeutics (United States)), Samuel R. Meier, Hannah Stowe(Massachusetts General Hospital), Minjie Zhang(Xian Yang Central Hospital), Katerina Pashiardis(Tango Therapeutics (United States)), Charlotte B. Pratt(Tango Therapeutics (United States)), Matthew R. Tonini(Tango Therapeutics (United States)), Hilary E. Nicholson(Harvard University)
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
October 15, 2025
Cited by 1
Related Papers
A Mutation in the LDL Receptor–Related Protein 5 Gene Results in the Autosomal Dominant High–Bone-Mass Trait
|The American Journal of Human Genetics|2002|1.3k
A Quantitative Proteome Map of the Human Body
|Cell|2020|485